MORROW GEORGE J - 17 May 2023 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
17 May 2023
Net transactions value
$0
Form type
4
Filing time
19 May 2023, 17:18:19 UTC
Previous filing
20 May 2022
Next filing
31 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Restricted Stock Unit Award $0 +4,199 $0.000000 4,199 17 May 2023 Common Stock 4,199 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F2 The Restricted Stock Units will vest in full on May 17, 2024.